Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
LMAT
↓ PDF (Pro)LeMaitre Vascular Inc. Common Stock
HealthcareMedical Instruments & SuppliesUnited StatesNASDAQ
$108.69
-2.96%today
MKT CAP
$2.5B
-7.6% · 1Y
Earnings History
-3.6%
+6.1%
+33.1%
+2.4%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$108.69
Low
$94.00
Analyst Mean
$111.22
High
$124.00
9 analystsNone
Full Financials
Trailing P/E39.7x
Forward P/E33.2x
EV/EBITDA-
Price/Sales-
Dividend Yield93.00%
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ+5.6%
5y Revenue CAGR+15.6%
5y Earnings CAGR+40.9%
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership6.9%
Institutional Ownership96.7%
Short % of Float7.55%
Days to Cover5.4d
1 Week+0.7%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| PELLEGRINO JOSEPH P JR | Director | Conversion | 2,941 | $35.48 | $0.10M | 2026-04-22 |
| KAMKE TRENT G | Officer | Sale | 2,625 | $108.50 | $0.28M | 2026-03-11 |
| KAMKE TRENT G | Officer | Conversion | 2,625 | $35.48 | $0.09M | 2026-03-11 |
| ROBERTS DAVID BRIAN | President | Sale | 3,311 | $107.68 | $0.36M | 2026-03-11 |
| LEBLANC DORIAN PAUL CPA | Chief Financial Officer | Other | 2 | - | - | 2026-03-10 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Blackrock Inc. | institution | 13.71% | $0.35B | +0.62% | 2025-12-31 |
| Vanguard Group Inc | institution | 7.10% | $0.18B | +1.37% | 2025-12-31 |
| Conestoga Capital Advisors, LLC | institution | 6.46% | $0.17B | +3.64% | 2026-03-31 |
| iShares Trust-iShares Core S&P Small-Cap ETF | fund | 5.49% | $0.14B | -1.13% | 2026-03-31 |
| Conestoga Funds-Conestoga Small Cap Fund | fund | 4.31% | $0.11B | -12.28% | 2025-12-31 |
| First TRT Exch-Trd Fd. VI-First TRT SMID Cap Rising Dividend Achievers | fund | 4.14% | $0.11B | +2.33% | 2026-03-31 |
| First Trust Advisors LP | institution | 4.11% | $0.11B | +13.41% | 2025-12-31 |
| Copeland Capital Management, LLC | institution | 3.89% | $0.10B | -5.46% | 2025-12-31 |
| Congress Asset Management Co | institution | 3.65% | $0.09B | +13.96% | 2026-03-31 |
| Geneva Capital Management LLC | institution | 3.57% | $0.09B | -10.70% | 2025-12-31 |
| State Street Corporation | institution | 3.53% | $0.09B | +0.77% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.84% | $0.07B | +0.48% | 2025-12-31 |
| Geode Capital Management, LLC | institution | 2.77% | $0.07B | +20.09% | 2025-12-31 |
| iShares Trust-iShares Russell 2000 ETF | fund | 2.21% | $0.06B | +1.03% | 2026-03-31 |
| Dimensional Fund Advisors LP | institution | 2.08% | $0.05B | +2.85% | 2025-12-31 |
| Professionally Managed Portfolios-Congress Small Cap Growth Fund | fund | 1.95% | $0.05B | +1.14% | 2026-03-31 |
| Nationwide Mutual Funds-Nationwide Geneva Small Cap Growth Fund | fund | 1.09% | $0.03B | -18.18% | 2026-01-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.98% | $0.03B | +1.30% | 2025-12-31 |
| T. ROWE PRICE QUANTITATIVE Mgmt Fd.S, INC.-T. Rowe Price Integrated U. | fund | 0.92% | $0.02B | +0.00% | 2025-12-31 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | fund | 0.88% | $0.02B | -1.18% | 2026-01-31 |
| Ticker | Cap | Score | P/E | Fwd P/E | EV/EBITDA | ROE | Gross | D/E | Div |
|---|---|---|---|---|---|---|---|---|---|
| WRBY | $2.7B | 24 | 2167.0 | 31.8 | - | - | - | - | 0.00% |
| XRAY | $2.3B | 100 | - | 7.1 | - | - | - | - | 504.00% |
| ICUI | $3.0B | 47 | 2989.8 | 13.0 | - | - | - | - | 0.00% |
| MMSI | $3.7B | 62 | 26.2 | 13.8 | - | - | - | - | 0.00% |
| NVST | $4.4B | 36 | 59.2 | 15.5 | - | - | - | - | 0.00% |
| ATRC | $1.4B | 5 | - | 78.8 | 71.0 | -1.0% | 76% | 15.24 | 0.00% |
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for LMAT.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.